Shire (NSDQ:SHPG) said late yesterday it agreed to Takeda Pharmaceutical‘s (TYO:4502) reworked acquisition bid, now worth approximately $64.2 billion (GBP £46 billion).
The takeover offer will now go to Shire’s shareholders for approval, having received backing from Dublin, Ireland-based Shire’s board of directors, according to a press release.
Read the whole story on our sister site, Drug Delivery Business
The post Shire accepts $64B takeover bid from Takeda appeared first on MassDevice.
from MassDevice https://ift.tt/2vOUTfm
Cap comentari:
Publica un comentari a l'entrada